Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

Abstract • About • The 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Diabetes

  Free Subscription


24.11.2025

2 Am J Ophthalmol
1 Ann Intern Med
3 Biochem Biophys Res Commun
1 BMC Ophthalmol
1 Br J Ophthalmol
1 Circ Arrhythm Electrophysiol
1 Circ Cardiovasc Qual Outcomes
10 Diabet Med
16 Diabetes
16 Diabetes Care
12 Diabetes Obes Metab
8 Diabetologia
2 Eur J Endocrinol
2 Invest Ophthalmol Vis Sci
6 J Clin Endocrinol Metab
2 J Clin Invest
5 J Diabetes Complications
1 J Nutr
2 Lancet
1 Med J Aust
1 Metabolism
1 Nature
2 Pediatr Diabetes
11 PLoS One
1 Retina


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Ophthalmol

  1. ANOZIE CC JR, Cox VF, Wiseman MT Jr, Lewis JE, et al
    Racial and ethnic disparities in risk for adverse ocular events in patients with diabetic retinopathy.
    Am J Ophthalmol. 2025 Nov 12:S0002-9394(25)00593.
    PubMed         Abstract available

  2. HUSSAIN ZS, Chauhan MZ, Muayad J, Loya A, et al
    Potency Matters: The Role of Statin Intensity in Modulating Risk for Age-Related Macular Degeneration.
    Am J Ophthalmol. 2025 Aug 17:S0002-9394(25)00430.
    PubMed         Abstract available


    Ann Intern Med

  3. JUNG M, Reisert M, Rieder H, Rospleszcz S, et al
    Association Between Body Composition and Cardiometabolic Outcomes : A Prospective Cohort Study.
    Ann Intern Med. 2025 Sep 30. doi: 10.7326/ANNALS-24-01863.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  4. RIVELLI ANTONELLI JF, Santander VS, Campetelli AN, Monesterolo NE, et al
    Tubulin-aldose reductase-Na(+)/K(+)-ATPase axis in diabetes: Molecular mechanisms and new pharmacological perspectives.
    Biochem Biophys Res Commun. 2025;792:152961.
    PubMed         Abstract available

  5. LIN J, Lin Y, Li J, Liu Q, et al
    Carboxyl ester lipase truncation mutant unveils lipotoxicity induced pancreatic beta-cell demise.
    Biochem Biophys Res Commun. 2025;789:152800.
    PubMed         Abstract available

  6. NGABEA MA, Dimeji IY
    GLP-1 receptor agonists and inflammatory pathway modulation: Dual targeting of metabolic and immune dysfunction in insulin resistance.
    Biochem Biophys Res Commun. 2025;789:152822.
    PubMed         Abstract available


    BMC Ophthalmol

  7. HAFNER M, Herold TR, Deiters V, Livonius BV, et al
    Quantitative comparison of a novel wide-field OCT-angiography device with ultrawide-field fluorescein angiography in detecting retinal nonperfusion in vascular retinopathies.
    BMC Ophthalmol. 2025;25:642.
    PubMed         Abstract available


    Br J Ophthalmol

  8. CHOE S, Xi C, Park DY, Kang KH, et al
    Synergistic effects of glaucoma, degeneration of macula and posterior pole, and diabetic ophthalmic complications on vision loss.
    Br J Ophthalmol. 2025 Nov 17:bjo-2025-327643. doi: 10.1136/bjo-2025-327643.
    PubMed         Abstract available


    Circ Arrhythm Electrophysiol

  9. GUO J, Song Z, Wang S, Yao D, et al
    Effect of Semaglutide on Atrial Arrhythmias Recurrence Following Ablation for Atrial Fibrillation: A Prospective Study.
    Circ Arrhythm Electrophysiol. 2025 Oct 9:e014069. doi: 10.1161/CIRCEP.125.014069
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  10. OSERAN AS, Aggarwal R, Wadhera RK
    Cardiovascular Risk Factor Management in Medicare Advantage and Traditional Medicare.
    Circ Cardiovasc Qual Outcomes. 2025 Oct 9:e012143.
    PubMed         Abstract available


    Diabet Med

  11. HABTE-ASRES HH, Stedman M, Forbes A, Karalliedde J, et al
    Incidence and risk factors for chronic kidney disease in individuals with type 1 diabetes: A population-based study in Salford, Manchester.
    Diabet Med. 2025 Nov 20:e70175. doi: 10.1111/dme.70175.
    PubMed         Abstract available

  12. ZHANG L, Wang J, Tan B, Wang X, et al
    Gastric bypass surgery improves lipid metabolism and mitochondrial function through the glutamate receptor Grin3a-mediated CaMKKbeta/AMPK pathway in a rat model of type 2 diabetes.
    Diabet Med. 2025 Nov 19:e70170. doi: 10.1111/dme.70170.
    PubMed         Abstract available

  13. KIRKWOOD JR, Galloway N, Lindsay RS, Manataki A, et al
    The use of machine learning to predict pharmacological therapy in gestational diabetes: A scoping review.
    Diabet Med. 2025 Nov 18:e70171. doi: 10.1111/dme.70171.
    PubMed         Abstract available

  14. MCGOWN P, Papanikolaou N, El-Taraboulsi J, Britton C, et al
    Real-world use of continuous glucose monitoring in people with type 2 diabetes and chronic kidney disease or on dialysis.
    Diabet Med. 2025 Nov 18:e70174. doi: 10.1111/dme.70174.
    PubMed         Abstract available

  15. HAYNES A, Besancon S, Maniam J, Beran D, et al
    Reply to Manne-Goehler et al. regarding 'Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali: A randomised controlled trial'.
    Diabet Med. 2025 Nov 17:e70159. doi: 10.1111/dme.70159.
    PubMed        

  16. ABILD CB, Vestergaard ET, Pauls DD, Bruun JM, et al
    Psychometric properties and factor structure of the diabetes eating problem survey revised in Danish adolescents with type 1 diabetes.
    Diabet Med. 2025 Nov 15:e70158. doi: 10.1111/dme.70158.
    PubMed         Abstract available

  17. MANNE-GOEHLER J, Roglic G
    Reply to Besancon et al. regarding 'Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali: A randomised controlled trial'.
    Diabet Med. 2025 Nov 14:e70097. doi: 10.1111/dme.70097.
    PubMed        

  18. MANJELIEVSKAIA J, Shah VN, Carlson AL, Isaacs D, et al
    Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021.
    Diabet Med. 2025;42:e70147.
    PubMed         Abstract available

  19. LAWTON J, Kyle CJ, Chambers TJG, Steven L, et al
    What training and support do people need to make optimal use of automated insulin delivery systems: Interview study.
    Diabet Med. 2025;42:e70153.
    PubMed         Abstract available

  20. CROWLEY MT, Ng N, Goulden E, Sanchez-Lechuga B, et al
    Sulphonylurea efficacy and end-organ outcomes in the management of HNF4A-MODY.
    Diabet Med. 2025;42:e70139.
    PubMed         Abstract available


    Diabetes

  21. LIU JJ, Liu S, Zheng H, Wang CP, et al
    Urinary Branched-Chain Amino Acid Excretion and Chronic Kidney Disease Progression in Patients With Type 2 Diabetes.
    Diabetes. 2025 Nov 21:db250782. doi: 10.2337/db25-0782.
    PubMed         Abstract available

  22. NGUYEN CM, Seldin M
    From Methylation to Metabolism: Linking Molecular Layers in Diabetes Risk.
    Diabetes. 2025;74:2214-2215.
    PubMed        

  23. SATTAR N
    Atherosclerotic Cardiovascular Risk Before and After Type 2 Diabetes Onset and the Roles of Ectopic Fat and Ethnic Variation: The 2025 Edwin Bierman Award Lecture.
    Diabetes. 2025;74:2223-2230.
    PubMed         Abstract available

  24. PAGE B
    Diabetes Spotlight: Sylvaine You, PhD-Preventing the Progression of Type 1 Diabetes Through Immunomodulatory Therapeutics.
    Diabetes. 2025;74:2153-2154.
    PubMed        

  25. GUO L, Wu P, Li Q, Feng Q, et al
    NUAK1 Promotes Diabetic Kidney Disease by Accelerating Renal Tubular Senescence via the ROS/P53 Axis.
    Diabetes. 2025;74:2405-2417.
    PubMed         Abstract available

  26. RUCHI FNU, Schiavon M, Pandey A, Dalla Man C, et al
    Postprandial Glucagon Metabolism in Healthy and Type 1 Diabetes.
    Diabetes. 2025 Nov 20:db250587. doi: 10.2337/db25-0587.
    PubMed         Abstract available

  27. STANLEY SA
    Neural Regulation of Blood Glucose in Acute Stress: A Report on Research Supported by Pathway to Stop Diabetes.
    Diabetes. 2025 Nov 18:dbi240051. doi: 10.2337/dbi24-0051.
    PubMed         Abstract available

  28. ENGAL E, Gershon A, Melamed S, Sharma A, et al
    Gestational Diabetes Mellitus Alters Placental Precursor mRNA Splicing.
    Diabetes. 2025 Nov 18:db250333. doi: 10.2337/db25-0333.
    PubMed         Abstract available

  29. GALDERISI A, Carr ALJ, Taylor P, Bonet J, et al
    Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes.
    Diabetes. 2025 Nov 14:db250801. doi: 10.2337/db25-0801.
    PubMed         Abstract available

  30. DEUTSCH AJ, Bell AS, Michalek DA, Burkholder AB, et al
    Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score.
    Diabetes. 2025 Nov 14:db250772. doi: 10.2337/db25-0772.
    PubMed         Abstract available

  31. PITA-GRISANTI V, Martins Pecanha FL, Louzada RA, Blandino-Rosano M, et al
    Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion.
    Diabetes. 2025 Nov 14:db250348. doi: 10.2337/db25-0348.
    PubMed         Abstract available

  32. SCHORMAIR K, Zhong J, Rico LDM, Wang N, et al
    Use of UCHL1 Gene Expression to Estimate Adipocyte Size.
    Diabetes. 2025;74:2291-2300.
    PubMed         Abstract available

  33. DAGOGO-JACK S
    Pathobiology of Prediabetes: Understanding and Interrupting Progressive Dysglycemia and Associated Complications.
    Diabetes. 2025;74:2155-2167.
    PubMed         Abstract available

  34. HAMPE CS, Kamat V, Bryan CL, Pyle L, et al
    Deleterious Effects of a GAD65 Monoclonal Autoantibody on Islet Function.
    Diabetes. 2025 Oct 10:db250475. doi: 10.2337/db25-0475.
    PubMed         Abstract available

  35. JI S, Shu H, Zhao H, Jiang H, et al
    Genotype-Phenotype Discrepancies in Family Members With a Novel Glucokinase Mutation: Insights Into GCK-MODY and Its Interplay With Insulin Resistance.
    Diabetes. 2025;74:2337-2350.
    PubMed         Abstract available

  36. DEFRONZO RA, Auchus RJ
    Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review.
    Diabetes. 2025;74:2168-2178.
    PubMed         Abstract available


    Diabetes Care

  37. MA RCW, Lin H, Yu G
    Unravelling Diabetes Endotypes and Associated Pathophysiology for Precision Medicine in Diabetes: Ready for Prime Time?
    Diabetes Care. 2025;48:2000-2003.
    PubMed        

  38. UNNIKRISHNAN R, Mohan V
    Remission of Type 2 Diabetes: Many Paths to the Same Goal.
    Diabetes Care. 2025;48:2010-2011.
    PubMed        

  39. ZHANG C, Wang B
    Revisiting the Link Between Meat Intake and the Risk of Type 2 Diabetes in American Indians: Insights Based on Lipidomic Profiles.
    Diabetes Care. 2025;48:1997-1999.
    PubMed        

  40. NIEMAN LK, Muniyappa R
    Unmasking Hypercortisolism in Difficult-to-Control Type 2 Diabetes: A Useful Paradigm Shift?
    Diabetes Care. 2025;48:1994-1996.
    PubMed        

  41. LI C, Fan W
    Comment on Samovski et al. Effect of Marked Weight Loss on Adipose Tissue Biology in People With Obesity and Type 2 Diabetes. Diabetes Care 2025;48:1342-1351.
    Diabetes Care. 2025;48:e180.
    PubMed        

  42. ROJAS PL, Nadeem S
    Disparities in Continuous Glucose Monitor Uptake Among Veterans With Diabetes Despite Universal Coverage.
    Diabetes Care. 2025;48:e183.
    PubMed        

  43. SAMOVSKI D, Smith GI, Palacios H, Pietka T, et al
    Response to Comment on Samovski et al. Effect of Marked Weight Loss on Adipose Tissue Biology in People With Obesity and Type 2 Diabetes. Diabetes Care 2025;48:1342-1351.
    Diabetes Care. 2025;48:e181-e182.
    PubMed        

  44. GRAHAM TE, Raghinaru D, Afreen S, Ahmann A, et al
    Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes.
    Diabetes Care. 2025;48:2154-2159.
    PubMed         Abstract available

  45. SNAITH JR, Frampton R, Samocha-Bonet D, Greenfield JR, et al
    Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial.
    Diabetes Care. 2025 Nov 20:dc252379. doi: 10.2337/dc25-2379.
    PubMed         Abstract available

  46. GOSHRANI A, Lin R, Churilov L, Gaca M, et al
    The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping Review.
    Diabetes Care. 2025 Nov 20:dc251508. doi: 10.2337/dc25-1508.
    PubMed         Abstract available

  47. KAHKOSKA AR, Neumiller JJ, Alexopoulos AS, Barik A, et al
    Challenges and Opportunities for Improving Care for Type 1 Diabetes in Older Adulthood.
    Diabetes Care. 2025 Nov 20:dci250078. doi: 10.2337/dci25-0078.
    PubMed         Abstract available

  48. RAN AR, Ding JL, Tang Z, Lam C, et al
    Real-World Prospective Validation and Economic Evaluation of Deep Learning-Based Diabetic Retinopathy Detection From Fundus Photographs: A Systematic Review and Meta-analysis.
    Diabetes Care. 2025 Nov 19:dc251493. doi: 10.2337/dc25-1493.
    PubMed         Abstract available

  49. CHOW EWK, Fan Y, Wu H, Lau ESH, et al
    Young-Onset Hypertension Confers Higher Risk of Cardiovascular Disease, Kidney Disease, and All-Cause Mortality in Individuals With Type 2 Diabetes: A Propensity Score-Matched Cohort Analysis.
    Diabetes Care. 2025 Nov 18:dc251839. doi: 10.2337/dc25-1839.
    PubMed         Abstract available

  50. KREIENKAMP RJ, Smith K, Wangden TY, Deutsch AJ, et al
    Novel Phenotypic Clusters of Youth-Onset Type 2 Diabetes Offer No Added Prognostic Value to Simple Clinical Measures.
    Diabetes Care. 2025 Nov 14:dc251765. doi: 10.2337/dc25-1765.
    PubMed         Abstract available

  51. LIU P, Yang J, Lee DH, Li LJ, et al
    Inflammatory and Insulinemic Dietary Patterns and Risk of Type 2 Diabetes Among Women With a History of Gestational Diabetes Mellitus: A Prospective Study of 84,174 Person-Years of Follow-up.
    Diabetes Care. 2025 Nov 14:dc251919. doi: 10.2337/dc25-1919.
    PubMed         Abstract available

  52. SATTAR N, Buse JB
    Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes Care.
    Diabetes Care. 2025 Nov 14:dci250069. doi: 10.2337/dci25-0069.
    PubMed         Abstract available


    Diabetes Obes Metab

  53. PAN C, Jiang H, Feng Y, Wang S, et al
    Efficacy and safety of bi-weekly cofrogliptin treatment replacing daily dipeptidyl peptidase-4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open-label, randomized controlled phase 2 trial.
    Diabetes Obes Metab. 2025 Nov 20. doi: 10.1111/dom.70305.
    PubMed         Abstract available

  54. SCARAMUZZA AE, Marigliano M, Moser O, Abate Daga F, et al
    Optimising the CamAPS FX automated insulin delivery system for exercise and complex meals in adolescents with type 1 diabetes: A prospective interventional study in a camp setting.
    Diabetes Obes Metab. 2025 Nov 20. doi: 10.1111/dom.70295.
    PubMed        

  55. YEO D, Jo Y, Jeong J, Jeong YD, et al
    Efficacy and safety of glucagon-like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials.
    Diabetes Obes Metab. 2025 Nov 19. doi: 10.1111/dom.70298.
    PubMed         Abstract available

  56. LI S, Chen L, Han Y, Jiang S, et al
    National trends in catastrophic health expenditures among US adults with diabetes aged 18-64 years: 2012-2021.
    Diabetes Obes Metab. 2025 Nov 18. doi: 10.1111/dom.70304.
    PubMed        

  57. WU Z, Alexandre-Heymann L, Lebbar M, Talbo MK, et al
    Despite lower haemoglobin A1c with second-generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A BETTER registry analysis.
    Diabetes Obes Metab. 2025 Nov 18. doi: 10.1111/dom.70299.
    PubMed         Abstract available

  58. ROSS MM, Mulnick S, Boye KS, Samuelson A, et al
    The value and impact of weight reduction from the perspective of people with type 2 diabetes in the United States.
    Diabetes Obes Metab. 2025 Nov 18. doi: 10.1111/dom.70290.
    PubMed         Abstract available

  59. POSTEMA A, Gaspersz J, Baak BN, Huisman EL, et al
    Real-world evaluation of clinical outcomes in Dutch patients with type 2 diabetes treated with oral semaglutide: A retrospective, observational cohort study using the PHARMO data network.
    Diabetes Obes Metab. 2025 Nov 17. doi: 10.1111/dom.70251.
    PubMed         Abstract available

  60. CHEN L, Wang L, Fu A, Yang J, et al
    Nomogram-based prediction of hypoglycemia risk in elderly community-dwelling patients with type 2 diabetes: Development and validation in a multicentre real-world cohort.
    Diabetes Obes Metab. 2025 Nov 17. doi: 10.1111/dom.70297.
    PubMed         Abstract available

  61. BHISE MR, Bhajipale NS, Babu RH, Tare MS, et al
    Comment on "Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes".
    Diabetes Obes Metab. 2025 Nov 17. doi: 10.1111/dom.70294.
    PubMed        

  62. SEO DH, Min KW, Sohn HS, Kim SY, et al
    Lobeglitazone improves glycaemic control as add-on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double-blind, randomised, placebo-controlled trial.
    Diabetes Obes Metab. 2025 Nov 14. doi: 10.1111/dom.70257.
    PubMed         Abstract available

  63. WENG CH, Bennett CL, Magagnoli J, Chou CC, et al
    Concerns regarding "GLP-1RA and the risk of non-arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes".
    Diabetes Obes Metab. 2025 Nov 14. doi: 10.1111/dom.70293.
    PubMed        

  64. ADAMS J, Saha S, Fleetwood KJ, Blackbourn LAK, et al
    Prescribing of glucose-lowering medication to adults with type 2 diabetes by severe mental illness status in Scotland: A cohort study.
    Diabetes Obes Metab. 2025 Nov 14. doi: 10.1111/dom.70278.
    PubMed         Abstract available


    Diabetologia

  65. GUPTA L, Misra A
    From malnutrition-related diabetes mellitus to 'type 5 diabetes': phenotypic variation, not reclassification.
    Diabetologia. 2025 Nov 22. doi: 10.1007/s00125-025-06607.
    PubMed        

  66. ZHU D, Ma J, Wang W, Shi B, et al
    Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial.
    Diabetologia. 2025 Nov 21. doi: 10.1007/s00125-025-06593.
    PubMed         Abstract available

  67. NERUP J, Lernmark A
    The rise and fall of a paradigm and conceiving a new hypothesis for type 1 diabetes.
    Diabetologia. 2025 Nov 21. doi: 10.1007/s00125-025-06610.
    PubMed        

  68. HEIN M, Qambari H, Yu P, Mehnert A, et al
    Interpericyte tunnelling nanotube loss in very early diabetic retinal disease.
    Diabetologia. 2025 Nov 20. doi: 10.1007/s00125-025-06602.
    PubMed         Abstract available

  69. WOUTERS A, Lemaitre P, Degroote L, Viaene M, et al
    Redosing of anti-CD3 antibodies in NOD mice with new-onset diabetes does not alter the effect of a single treatment course.
    Diabetologia. 2025 Nov 20. doi: 10.1007/s00125-025-06604.
    PubMed         Abstract available

  70. BAJRAMAGIC M, Battelino T, Cos X, Cote M, et al
    Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmap.
    Diabetologia. 2025 Nov 17. doi: 10.1007/s00125-025-06601.
    PubMed         Abstract available

  71. ZAITOON H, Perl L, Cohen-Sela E, Oren A, et al
    The virtual Morris water maze for cognitive function assessment in adolescents with type 1 diabetes.
    Diabetologia. 2025 Nov 17. doi: 10.1007/s00125-025-06598.
    PubMed         Abstract available

  72. WATANABE-SHIMOJI K, Tanabe H, Ohsugi M, Kawakami E, et al
    Diverse combination of factors associated with the development of diabetic kidney disease among data-driven diabetes subtypes: analysis of the J-DREAMS registry.
    Diabetologia. 2025 Nov 17. doi: 10.1007/s00125-025-06594.
    PubMed         Abstract available


    Eur J Endocrinol

  73. XIE L, Lu W, Yu J, Zhang Y, et al
    Regulation of insulin expression and release in gene and cell therapy of insulin-deficient diabetes.
    Eur J Endocrinol. 2025 Nov 18:lvaf231. doi: 10.1093.
    PubMed         Abstract available

  74. GONZALEZ-LUIS A, Llinares-Arvelo V, Martinez-Alberto CE, Hernandez-Carballo C, et al
    Glucagon-like peptide-1 receptor agonists and muscle health: potential role in sarcopenia prevention and treatment.
    Eur J Endocrinol. 2025;193:R31-R44.
    PubMed         Abstract available


    Invest Ophthalmol Vis Sci

  75. KAKIHARA S, Zhuang K, Fawzi AA
    Macular Deep Capillary Plexus Ischemia as a Biomarker for Identifying Referable Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:45.
    PubMed         Abstract available

  76. MAO Z, Yang W, Chao Y, Chen Z, et al
    Palmitic Acid Induces Ferroptosis in Retinal Microvascular Endothelial Cells by Palmitoylation of Keap1 to Affect Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:41.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  77. ODE KL, Imai Y, Norris AW
    Approach to the Patient with Pancreatogenic Diabetes.
    J Clin Endocrinol Metab. 2025 Nov 18:dgaf623. doi: 10.1210.
    PubMed         Abstract available

  78. CHANG S, Pedersen L, Skakkebaek A, Berglund A, et al
    Metabolism and type 2 diabetes across life stages in Klinefelter syndrome: a population-based cohort study.
    J Clin Endocrinol Metab. 2025 Nov 15:dgaf619. doi: 10.1210.
    PubMed         Abstract available

  79. KONGARA T, Carruth A, Bhat P, Virostko J, et al
    Determinants of Pancreatic Size and Fat Content in the UK Biobank: Influence of Race, Genetic Variants, and Risk Factors.
    J Clin Endocrinol Metab. 2025;110:e3945-e3951.
    PubMed         Abstract available

  80. RAMIREZ-LUZURIAGA MJ, Vazquez Arreola E, Hanson RL, Knowler WC, et al
    Familial Associations of Metabolic Syndrome and Its Interrelated Traits in Southwestern Indigenous Americans.
    J Clin Endocrinol Metab. 2025;110:e3962-e3971.
    PubMed         Abstract available

  81. FERMIN-MARTINEZ CA, Bello-Chavolla OY, Paz-Cabrera CD, Ramirez-Garcia D, et al
    Prediabetes and Risk of All-Cause and Cause-Specific Mortality: A Prospective Study of 114?062 Adults in Mexico City.
    J Clin Endocrinol Metab. 2025;110:3451-3460.
    PubMed         Abstract available

  82. KU EJ, Lee J, Yoo WS, Bae J, et al
    Long-Term Non-skeletal Complications in Patients with Thyroid Cancer and Hypoparathyroidism Post-total Thyroidectomy.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf213. doi: 10.1210.
    PubMed         Abstract available


    J Clin Invest

  83. WU L, Wentworth JM, Liddle C, Fewings N, et al
    Pancreatic volume and immune biomarkers predict checkpoint inhibitor-associated autoimmune diabetes in humans.
    J Clin Invest. 2025 Nov 20:e192938. doi: 10.1172/JCI192938.
    PubMed         Abstract available

  84. BHAGCHANDANI P, Ramos SA, Rodriguez B, Gu X, et al
    Curing autoimmune diabetes in mice with islet and hematopoietic cell transplantation after CD117 antibody-based conditioning.
    J Clin Invest. 2025 Nov 18:e190034. doi: 10.1172/JCI190034.
    PubMed         Abstract available


    J Diabetes Complications

  85. POHAN SD, Sauriasari R, Maggadani BP, Rukmana TI, et al
    Serum analysis of type 2 diabetes mellitus patients with low, moderate, and high risk of diabetic kidney disease using LC-MS metabolomics approach.
    J Diabetes Complications. 2025;40:109202.
    PubMed         Abstract available

  86. BRIGANTI SI, Lanza O, Renzelli V, Campagna G, et al
    Impact of technologies on quality of life in relation to glucose control in patients with type 1 diabetes.
    J Diabetes Complications. 2025;40:109215.
    PubMed         Abstract available

  87. GOLCHIN A, Johnson KC, Houston DK, Luchsinger JA, et al
    Associations of modifiable lifestyle and clinical factors with cognitive function in adults with type 2 diabetes.
    J Diabetes Complications. 2025;40:109227.
    PubMed         Abstract available

  88. SARI F, Bazancir-Apaydin Z, Sari S, Sari MC, et al
    Assessing the impact of dysphagia on quality of life and determining SWAL-QOL cut-off scores in diabetes mellitus patients: a data mining approach.
    J Diabetes Complications. 2025;39:109205.
    PubMed         Abstract available

  89. AYDOGAN HY, Demirci DK, Gul N, Yanar F, et al
    Gender differences in the distribution of IDL, LDL, and HDL lipoprotein subfractions in MODY compared to type 2 diabetes: Data from the MODY-Ist study.
    J Diabetes Complications. 2025;39:109196.
    PubMed         Abstract available


    J Nutr

  90. LIANG X, Li L, Lu H, Li Y, et al
    Body Selenium Status and Diabetes and Complications: The Multi-phased Effect of Selenium.
    J Nutr. 2025 Nov 12:S0022-3166(25)00696-0. doi: 10.1016/j.tjnut.2025.
    PubMed         Abstract available


    Lancet

  91. ROEP BO
    Personalised prevention therapy in type 1 diabetes.
    Lancet. 2025 Nov 11:S0140-6736(25)02005-7. doi: 10.1016/S0140-6736(25)02005.
    PubMed        

  92. ZIEGLER AG, Achenbach P, Weiss A, Berner R, et al
    Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial.
    Lancet. 2025 Nov 11:S0140-6736(25)01726-X. doi: 10.1016/S0140-6736(25)01726.
    PubMed         Abstract available


    Med J Aust

  93. NANAYAKKARA N, Atkinson-Briggs S, Jenkins AJ, Cohen ND, et al
    Rethinking diabetes care for Indigenous Australians: the need for Indigenous-codesigned and led diabetes models of care.
    Med J Aust. 2025 Nov 17. doi: 10.5694/mja2.70108.
    PubMed        


    Metabolism

  94. MUNOZ F, Gao Q, Mattanovich M, Trost K, et al
    Lysine potentiates insulin secretion via AASS-dependent catabolism and regulation of GABA content and signaling.
    Metabolism. 2026;174:156423.
    PubMed         Abstract available


    Nature

  95. BUNDELL S, Petric Howe N
    Insulin cream offers needle-free option for diabetes.
    Nature. 2025 Nov 19. doi: 10.1038/d41586-025-03803.
    PubMed        


    Pediatr Diabetes

  96. TAS E, Movva S, Muzumdar U, Libman I, et al
    Sex-Based Differences in BMI and LDL-C Trajectories Following Type 1 Diabetes Diagnosis in Youth.
    Pediatr Diabetes. 2025;2025:7996152.
    PubMed         Abstract available

  97. BAKKE KA, Brunborg C, Midtlyng E, Helverschou SB, et al
    Comorbidity of Type 1 Diabetes and ADHD: A Longitudinal Cohort Study in Males and Females From the Norwegian Childhood Diabetes Registry.
    Pediatr Diabetes. 2025;2025:9574797.
    PubMed         Abstract available


    PLoS One

  98. MARTINEZ-SANTOS M, Ybarra M, Pires ME, Ceresoni C, et al
    Circulating microRNAs as biomarkers for diabetic retinopathy stage identification: A DTA systematic review and meta-analysis.
    PLoS One. 2025;20:e0335434.
    PubMed         Abstract available

  99. PENG M, Shen P, Joung KI, Kim KJ, et al
    Safety profile of metformin in adolescents with type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System.
    PLoS One. 2025;20:e0337204.
    PubMed         Abstract available

  100. LI K, Fu W, Liu Y, Xue J, et al
    Dietary fiber inulin mitigates peripheral neuropathy in different stages of diabetes via modulating gut microbiota and metabolites in db/db mice.
    PLoS One. 2025;20:e0336962.
    PubMed         Abstract available

  101. HU S, Wu Z, Liu X, Ding Y, et al
    The role and mechanism of irisin/NLRP3 signal in aerobic exercise ameliorating blood glucose homeostasis in pre-diabetic mice.
    PLoS One. 2025;20:e0336395.
    PubMed         Abstract available

  102. JIN Z, Wang H, Wen HB
    Sleep duration and cardiovascular disease risk in type 2 diabetes: A prospective cohort study.
    PLoS One. 2025;20:e0337232.
    PubMed         Abstract available

  103. WANG N, Kong J, Lu Z, Cao F, et al
    Effects of SGLT-2 inhibitors on renin-angiotensin-aldosterone system and their correlation with glucose metabolism in type 2 diabetes mellitus patients with hypertension: A prospective study.
    PLoS One. 2025;20:e0336158.
    PubMed         Abstract available

  104. SPENCER J, Bahuguna M, Ramani S, Pathak S, et al
    What constitutes 'poor' adherence to medical advice for chronic diseases? Insights from a qualitative study among hypertension and diabetes patients in urban informal settlements, Mumbai Metropolitan Region.
    PLoS One. 2025;20:e0324765.
    PubMed         Abstract available

  105. HE W, Chen J
    Computational identification of novel SIRT4 inhibitors for diabetic nephropathy using pharmacophore modeling, molecular simulations, and DFT calculations.
    PLoS One. 2025;20:e0336948.
    PubMed         Abstract available

  106. TENEZOGANG TAKOUKAM C, Tchamadeu MC, Ateba SB, Yousseu Nana W, et al
    Antioxidant and antidiabetic effects of Angylocalyx oligophyllus leaves aqueous extract in pregnant diabetic rats: Feto-maternal repercussions.
    PLoS One. 2025;20:e0334166.
    PubMed         Abstract available

  107. SHUDAYFAT M, Taybeh EO, Alsous M
    The effect of antenatal psychological well-being on maternal health status.
    PLoS One. 2025;20:e0336684.
    PubMed         Abstract available

  108. FAN Y, Li L, Du F, Ren J, et al
    Mediterranean Diet reduces ischemic heart disease risk in diabetes patients until reversed by smoking: Evidence from UK Biobank cohort.
    PLoS One. 2025;20:e0336414.
    PubMed         Abstract available


    Retina

  109. MARIACRISTINA P, Eliana C, Daniele G, Monica V, et al
    DRSplus retinographer in patients with diabetes: a comparison study by consensus grading, Reading Center and Artificial Intelligence.
    Retina. 2025 Nov 12. doi: 10.1097/IAE.0000000000004734.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.